Navigation Links
Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Date:11/13/2008

CORONA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for a 6-month formulation of TRELSTAR(R) (triptorelin pamoate), a luteinizing hormone releasing hormone (LHRH) agonist, has been accepted for filing by the U.S. Food and Drug Administration (FDA). Watson is seeking marketing approval of this TRELSTAR(R) formulation for the palliative treatment of advanced prostate cancer. Watson anticipates that FDA will take action on its application in the third quarter 2009.

The sustained-release formulation of TRELSTAR(R) is designed to suppress the production of testosterone in men with advanced prostate cancer over 6 months. Prostate cancer growth is regulated in part by the level and activity of testosterone.

"This filing reflects Watson's commitment to urology and to making a difference in the lives of men living with prostate cancer," said Paul Bisaro, Watson's President and Chief Executive Officer. "This new longer duration TRELSTAR(R) formulation requires only one injection every 24 weeks, and showed comparable efficacy and safety with our marketed TRELSTAR(R) 1 and 3-month formulations. The TRELSTAR(R) 6-month formulation should be a welcome alternative for men and their physicians and will be a significant addition to our expanding urology portfolio."

About TRELSTAR(R)

TRELSTAR(R), developed by Debiopharm Group, a Swiss biopharmaceutical development specialist, and marketed by Watson Pharma, Inc., is a synthetic hormone known as a luteinizing hormone releasing hormone (LHRH) agonist, which suppresses the production of testosterone in the testicles. The growth of the prostate is reg
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Watson Pharmaceuticals Reports Third Quarter 2008 Results
2. Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
3. Older Workers Worried About Promised Medicare and Social Security Benefits, Watson Wyatt Survey Finds
4. Watson Wyatt Identifies Trends for Benefits Open Enrollment Season
5. Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
6. Watson Announces Limited Recall of Fentanyl Transdermal System
7. Watson Launches Omeprazole Delayed-Release Capsules, 40MG
8. Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris
9. Watson Launches Generic MARINOL(R) Capsules
10. Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
11. Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post that explains ... for flatbed trucks. , Flatbed trucks are used ... are mainly used for commercial purposes and thus require ... that by comparing multiple offers, drivers can find low ... , It is now possible to compare free online ...
(Date:4/25/2015)... Gardant Management Solutions will lead sessions ... and sales and marketing at the LeadingAge Illinois ... held from April 29 through May 1 in ... eldercare association in Illinois. The statewide association represents ... including senior housing, assisted living and supportive living ...
(Date:4/25/2015)... On Friday, April 17, Interstate Batteries was ... Implementation Award. This award is given to the ... RFID technology to improve its manufacturing, supply chain or ... demonstrates how RFID is delivering real value to shareholders. ... 2015 in San Diego, the RFID industries annual trade ...
(Date:4/24/2015)... Multi Customer Discount , Rules: This ... http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's Septics service ... does not include any Dig fees, or any other ... If someone is part of this group event and ... 2500 gallons or more, the cost would be $300.00. ...
(Date:4/24/2015)... Houston, TX (PRWEB) April 24, 2015 The ... Dan Long, after their great success of the Xtreme Fat ... the industry. The fat loss blueprint that claims to ... caught the attention of HealthyandFitZone.com's Stan Stevenson, prompting an investigative ... shows that the creators spent years researching and experimenting ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2
... executive, has warned that acute hospitals and Action and Emergency (A&E) ... health services deficit of ?512million. He added that ... may be combined in fewer units. ,He pointed out ... have to be maintained along with ...
... Tshwane University of Technology (TUT) have recommended shopping till ... not revenge on your husband or even your bank ... ,Department of sport and physical rehabilitation sciences ... the group of 40 students stumbled upon this finding ...
... has claimed 49 lives and affected 20,000 people in West ... Das told the West Bengal Assembly today. // ... as those of malignant malaria, Das said during mention hour., ... he said that it was far from adequate. Besides, there ...
... (INSH) ASHVINI located in Mumbai has been named the best ... ,Defence Minister Pranab Mukherjee awarded the Running trophy and a ... the hospital, Rear Admiral V K Saxena here today., ... functioning hospital among the Command Hospitals of the Indian Army ...
... moghul and UN Messenger for Peace, Vijay Amritraj, has ... India among HIV/AIDS victims. // ,The UN ... HIV/AIDS in India and only a fraction is getting ... medicines for the disease., ,Launching the `Amritraj Foundation' ...
... levels of benzene in two diet drinks, which has ... market. , ,The two drinks that have been ... Rose's Diabetic Squash Concentrate. Stricter guidelines have been enabled ... benzene formation in the drinks., ,Benzene, a ...
Cached Medicine News:
(Date:4/23/2015)... 23, 2015 Surna, Inc. (OTCQB: SRNA), a ... art equipment and systems for controlled environment agriculture ... cultivation, will host a shareholder conference call to ... at 4:15 PM Eastern Standard Time/1:15 PM Pacific ... will be listen-in only, but will include a ...
(Date:4/23/2015)... 2015 WellStar Health System continues to raise ... with the most advanced technology. WellStar Kennestone Hospital is ... to offer TomoTherapy and one of only two ... offer both TomoTherapy and CyberKnife, another leading cancer treatment. ... around the patient, which allows radiation to be delivered ...
(Date:4/23/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Deutsche Bank 40 th Annual Health Care ... You are invited to listen to the ... or access it directly at http://edge.media-server.com/m/p/yvym8uoy . ... one hour after conclusion of the live event and ...
Breaking Medicine Technology:Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3WellStar's New, Highly Targeted Therapy Shortens Cancer Treatment Time 2
... 2012 Glaucoma is the second leading cause of ... market with a significant opportunity to fulfill unmet medical ... glaucoma will expand as the population ages. ... Analysis of the United States Glaucoma Pharmaceuticals Market ...
... Shire plc (LSE: SHP, NASDAQ: SHPGY ... three months to March 31, 2012. Financial ... revenues million +21% Non GAAP operating income $362 million +18% ... earnings per ADS $1.48 +20% US GAAP diluted earnings per ...
Cached Medicine Technology:Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan 2Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan 3Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 2Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 3Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 4Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 5Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 6Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 7Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 8Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 9Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 10Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 11Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 12Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 13Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 14Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 15Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 16Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 17Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 18Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 19Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 20Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 21Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 22Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 23Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 24Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 25
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
Medicine Products: